Cipla Renews with X/procure® for 4th Consecutive Year

“Despite the tightening economy, and because sales of its advertised products show measured return on investment, Cipla has confirmed it will continue to make use of our procurement and advertising platform throughout 2009,” says X/Procure®'s Executive Director: Sales & Marketing JD Henderson.

As a means to launch new products on a project-by-project basis and to ensure high levels of awareness for current advertised products, the pharmaceutical manufacturer will make use of X/Procure®'s multi-tiered communication offerings. “An added advantage of using our system is that the communication is a one way channel of information straight from manufacturer to pharmacist, with no gateway in between,” adds JD.

“Pharmacists have access to the Cipla advertisements exactly when they are about to place their electronic orders,” he says. “Our system is mainly used by pharmacists for bulk ordering, providing an ideal opportunity for manufactures to advertise, promote and create awareness for their brands. Ask Cipla, it works!”

Brand DNA

X/procure® is a ground-breaking electronic procurement and advertising platform, which enables more than 50% of South African pharmacies to purchase scheduled and OTC pharmaceutical, surgical and front shop requirements directly from wholesalers and distributors. The X/procure® system also facilitates electronic advertising directly to the pharmacist, allowing advertisers the unique opportunity to present and promote their products at the time the buying decision is made.